-
Neurocrine Biosciences (NASDAQ:NBIX) Upgraded by StockNews.com to Strong-Buy Rating
Source: Buzz FX / 13 Mar 2025 22:26:16 America/Chicago
Neurocrine Biosciences (NASDAQ:NBIX) Upgraded by StockNews.com to Strong-Buy Rating Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Neurocrine Biosciences ( NASDAQ:NBIX - Get Free Report ) was upgraded by sto
Read more...